![Catherine Ley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Catherine Ley is Director of Virtual Biotech Services for CollabRx, Inc. Previously, she was Principal at Caradon Consulting and Senior Scientist and Epidemiologist at the Institute for OneWorld Health.
Ms. Ley received an MS degree and BS degree in Biological Sciences from Stanford University as well as PhD in Epidemiology from the University of California, Berkeley.
| Companies | Position | End |
|---|---|---|
CollabRx, Inc. /Old/
 CollabRx, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and manufactures cancer therapies | Corporate Officer/Principal | 26/09/2012 |
PATH Drug Solutions
 PATH Drug Solutions Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs and vaccines for Ebola disease | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PATH Drug Solutions
PATH Drug Solutions Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs and vaccines for Ebola disease | Commercial Services |
CollabRx, Inc. /Old/
CollabRx, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Develops and manufactures cancer therapies | Commercial Services |
Select your edition
All financial news and data tailored to specific country editions
